|Bid||143.50 x 200|
|Ask||144.29 x 200|
|Day's Range||141.75 - 144.19|
|52 Week Range||96.93 - 144.59|
|PE Ratio (TTM)||44.56|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Optimism that it can develop CAR-T cancer drugs that are better than its competitors' is trumping news that the company is diluting investors by selling more shares.
Juno Therapeutics (JUNO) launches a proposed follow-on public offering of shares. The company plans to utilize net proceeds from the offering for general corporate purposes.
Leaves might fall in autumn, but these big biotech stocks should rise.